C

CLDI

Calidi Biotherapeutics Inc

5.10

0.06+1.19%
Opening14:35 08/12 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Cash from Operating Activities

-19.69M

-26.98M

-13.21M

-7.77M

-4.83M

Net Income

-22.21M

-29.22M

-25.43M

-10.93M

-7.94M

Depreciation/Depletion & Amortization

402.00K

392.00K

260.00K

156.00K

107.00K

Deferred Taxes

--

--

--

--

--

Non-Cash Items

3.81M

8.08M

8.38M

1.40M

1.00M

Changes in Working Capital

-1.70M

-6.24M

3.57M

1.61M

2.00M

Cash from Investing Activities

-16.00K

-478.00K

-494.00K

-215.00K

-388.00K

Capital Expenditures

-16.00K

-585.00K

-428.00K

-206.00K

-351.00K

Other Investing Cash Flow Items, Total

--

107.00K

-66.00K

-9.00K

-37.00K

Cash from Financing Activities

27.36M

29.04M

12.09M

9.81M

4.70M

Financing Cash Flow Items

437.00K

3.37M

8.04M

6.78M

0

Total Cash Dividends Paid

--

--

--

--

--

Issuance (Retirement) of Stock, Net

25.01M

24.78M

114.00K

135.00K

2.82M

Issuance (Retirement) of Debt, Net

1.92M

899.00K

3.93M

2.90M

1.88M

Foreign Exchange Effects

-13.00K

-6.00K

-26.00K

-4.00K

3.00K

Net Change in Cash

7.64M

1.58M

-1.65M

1.82M

-514.00K

Cash Interest Paid

140.00K

404.00K

35.00K

45.00K

20.00K

Cash Taxes Paid

14.00K

11.00K

11.00K

8.00K

2.00K